Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986648 · ClinicalTrials.gov registry record
A Multi-Center Group to Study Acute Liver Failure in Children
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 158
- Enrollment target
NCT00986648: Completed study, sponsored by University of Pittsburgh.
NCT00986648 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 158 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986648 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 158 participants
- Enrollment target
Study Summary
The PALF study group began with 20 sites and now continues with 12 sites (11 in the United States and 1 in Canada) in the new funding period. The primary objective of the Pediatric Acute Liver Failure (PALF) study is to collect, maintain, analyze, and report clinical, epidemiological, and outcome data in children with ALF, including information derived from biospecimens.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2000-01 |
| Est. Completion | 2015-12 |
What the finished NCT00986648 record still lists
NCT00986648 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00986648 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986648 about?
NCT00986648 is a clinical study titled "A Multi-Center Group to Study Acute Liver Failure in Children". The PALF study group began with 20 sites and now continues with 12 sites (11 in the United States and 1 in Canada) in the new funding period. The primary objective of the Pediatric Acute Liver Failure (PALF) study is to collect, maintain, analyze, and report clinical, epidemiological, and outcome da...
What is the current status of trial NCT00986648?
This trial is currently completed. The enrollment target is 158 participants. The study started on 2000-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00986648?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia